Cyrus Biotechnology Inc. products

CRISPR technology, developed from a bacterial enzyme system that recognizes and edits Clustered, Regularly Interspaced Short Palindromic Repeats, and which protects bacteria from viruses, also enables the precise manipulation of genetic information and has the potential to provide substantial benefit. As the technology has matured, CRISPR gene editing has started advancing from ex vivo applications (manipulation of DNA in cells removed from the body which are then reimplanted in the body) to in vivo applications (manipulation of DNA in a patient by infusion of CRISPR enzyme systems into the body).